Optimal treatment of Imipenem and meropenem against bloodstream infections caused by the Citrobacter spp
Cfr is the most common BSIs. Citrobacter spp. PIT is more adequate to provide activity against BSIs Citrobacter spp., especially for IPM.
Authors
- Junpeng Yue
- Jiaheng Fang
- Wei Yu (ORCID: https://orcid.org/0000-0002-1174-596X)
- Yunqing Qiu
- Lushun Jiang (ORCID: https://orcid.org/0000-0002-4026-7418)
- Jiajie Zhang (ORCID: https://orcid.org/0000-0002-3510-4040)
- Jiaying Shen (ORCID: https://orcid.org/0009-0005-8418-2431)
- Kanghui Zhang (ORCID: https://orcid.org/0000-0003-1628-1647)
- Kaixuan Dong
Institutions
- Affiliated Hospital of Hangzhou Normal University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou Medical College (CN)
- State Key Laboratory of Diagnosis and Treatment of Infectious Diseases
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1186/s12879-025-10760-6
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Health of Zhejiang Province